NO20012423D0 - Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser - Google Patents

Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser

Info

Publication number
NO20012423D0
NO20012423D0 NO20012423A NO20012423A NO20012423D0 NO 20012423 D0 NO20012423 D0 NO 20012423D0 NO 20012423 A NO20012423 A NO 20012423A NO 20012423 A NO20012423 A NO 20012423A NO 20012423 D0 NO20012423 D0 NO 20012423D0
Authority
NO
Norway
Prior art keywords
convulsant
post
treatment
traumatic stress
derivatives useful
Prior art date
Application number
NO20012423A
Other languages
English (en)
Other versions
NO20012423L (no
Inventor
Daniel P Van Kammen
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20012423L publication Critical patent/NO20012423L/no
Publication of NO20012423D0 publication Critical patent/NO20012423D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20012423A 1998-11-17 2001-05-16 Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser NO20012423D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10880598P 1998-11-17 1998-11-17
PCT/US1999/021612 WO2000028945A2 (en) 1998-11-17 1999-10-12 Anticonvulsant derivatives useful in treating post traumatic stress disorder

Publications (2)

Publication Number Publication Date
NO20012423L NO20012423L (no) 2001-05-16
NO20012423D0 true NO20012423D0 (no) 2001-05-16

Family

ID=22324143

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012423A NO20012423D0 (no) 1998-11-17 2001-05-16 Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser

Country Status (15)

Country Link
US (1) US6472370B1 (no)
EP (1) EP1143917B1 (no)
CN (1) CN1326346A (no)
AT (1) ATE261724T1 (no)
AU (1) AU764510B2 (no)
BR (1) BR9915434A (no)
CA (1) CA2351658C (no)
DE (1) DE69915690T2 (no)
DK (1) DK1143917T3 (no)
ES (1) ES2217819T3 (no)
HU (1) HUP0105037A3 (no)
NO (1) NO20012423D0 (no)
NZ (1) NZ511881A (no)
PT (1) PT1143917E (no)
WO (1) WO2000028945A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1187604A4 (en) * 1999-05-28 2004-02-11 Jeffrey Berlant CONNECTIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS FAILURES
CA2430010A1 (en) 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
WO2004027027A2 (en) 2002-09-18 2004-04-01 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
US20060258698A1 (en) 2005-02-09 2006-11-16 Sreenivasu Mudumba Liquid formulations for treatment of diseases or conditions
US8492400B2 (en) 2006-02-09 2013-07-23 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
JP5506378B2 (ja) 2006-03-23 2014-05-28 参天製薬株式会社 血管透過性に関連する疾患または病気のための製剤および方法
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5753693A (en) * 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder

Also Published As

Publication number Publication date
EP1143917A2 (en) 2001-10-17
ATE261724T1 (de) 2004-04-15
US6472370B1 (en) 2002-10-29
BR9915434A (pt) 2001-12-04
AU764510B2 (en) 2003-08-21
DE69915690T2 (de) 2005-02-24
EP1143917A3 (en) 2002-01-02
HUP0105037A2 (hu) 2002-04-29
ES2217819T3 (es) 2004-11-01
NO20012423L (no) 2001-05-16
CN1326346A (zh) 2001-12-12
WO2000028945A3 (en) 2001-09-20
DK1143917T3 (da) 2004-06-01
PT1143917E (pt) 2004-06-30
CA2351658C (en) 2006-07-11
EP1143917B1 (en) 2004-03-17
WO2000028945A2 (en) 2000-05-25
NZ511881A (en) 2004-12-24
HUP0105037A3 (en) 2003-01-28
AU6393399A (en) 2000-06-05
CA2351658A1 (en) 2000-05-25
DE69915690D1 (de) 2004-04-22

Similar Documents

Publication Publication Date Title
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
DK1144388T3 (da) Acyl-derivater, som behandler VLA-4-relaterede lidelser
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
DE69713347D1 (de) Flammbehandlungsverfahren
DE69925571D1 (de) Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20013493L (no) Anvendelse av neurotrofin samt analoger derav ved behandling av gastrointestinale hypomotilitetslidelser
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
NO20012423L (no) Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser
BR9609631A (pt) Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca
NO20010456L (no) Triazolopyridiner for behandling av trombose lidelser
DK0932400T3 (da) Antikonvulsive derivater, der er nyttige ved behandling af neuropatisk smerte
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO990450D0 (no) Behandling av sinnslidelser
PT1051172E (pt) Metodo para tratamento da dpco
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
BR0210678A (pt) Carbamatos de 2-heterocìclicos-1,2-etanodióis
BR9909878A (pt) 10-canfosulfonato de paroxetina para tratamento de distúrbios do sistema nervoso central

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application